Large molecule biologics development and commercialization

Meeting our customers’ unique molecule needs

Based on our unmatched experience with more than 1,000 molecules, including more than 50 large molecule (biologics) drug substances, Patheon pharma services brings deep scientific expertise to every challenge. We apply our comprehensive process development skills to significantly increase the batch yield and reduce processing time for your molecule. Our proven track record of scaling up biologics helps provide you with cost and time savings at every stage of development, with processes that ensure: 

  • Repeatability
  • Reliability
  • High quality and low cost
240

We have done 240 biologic development programs, providing you with the scientific and technical expertise you need to reduce risk

42% growth

The global demand for biologics has increased to 42 percent of the total clinical pipeline in the past 10 years

1,000+

We have developed more than 1,000 molecules in the last decade, including more than 50 large (biologics) drug substances

 

240

We have done 240 biologic development programs, providing you with the scientific and technical expertise you need to reduce risk

42% growth

The global demand for biologics has increased to 42 percent of the total clinical pipeline in the past 10 years

1,000+

We have developed more than 1,000 molecules in the last decade, including more than 50 large (biologics) drug substances

 

Large molecule solutions and capabilities

We understand the challenges and the need for flexibility and speed for meeting important milestones and can provide you with the strategic guidance and flexible solutions that are custom built on comprehensive capabilities and experience.

Our team of experts are driven by science and bring expertise along with a proven track record of scaling up biologics to help ensure you gain cost and time savings at every stage of your drug development process. With solutions like Patheon™ Quick to Clinic™ for large molecules that can help you go from transfection to IND in as little as 13 months, we have the expertise to ensure you get critical medicine to patients faster. From preclinical to commercial production, our global network of experts understands the long and complex large molecule journey and are committed to help speed your molecule through early phase trials and prepare you for commercial success, faster.

Helpful Resources 

The rapid 10 percent growth of sterile drug product over the past five years is being aided by the rise in biologics, orphan drugs, and oncology therapeutics, as well as other environmental factors. We understand the critical need for robust and flexible early development solutions, so you can:

 
  • Overcome complex formulation challenges: solubility, stability, process
  • Build a robust process development program
  • Navigate a complex regulatory environment (IND, filing, etc.)
  • Build success in early development to enable commercial success
  • Shorten timelines to get to market quicker